Acadia Pharmaceuticals Tech Stack

FDA-approved neuropsych treatments with mid-to-late-stage pipeline in cognitive disorders

Pharmaceutical Manufacturing San Diego, California 501–1,000 employees Public Company

Acadia is a mid-sized pharma manufacturer with two commercial products (Parkinson's disease psychosis and Rett syndrome treatments) and a pipeline focused on Alzheimer's and Lewy body dementia psychosis. The tech stack is pharma-conventional—Veeva CRM/Vault, Salesforce, Azure, NetSuite, Coupa—built for regulatory compliance and supply chain. Active hiring skews heavily toward senior roles (59 of 126 openings) across sales, ops, and healthcare functions, signaling simultaneous expansion of commercial reach and internal operational maturity, while projects cluster around inspection readiness, quality system digitization, and medication access logistics.

Tech Stack 20 technologies

Core StackZoom OneTrust Salesforce Power BI Smartsheet NetSuite Salesforce Marketing Cloud Veeva Adobe Experience Manager Microsoft Office Webex Veeva CRM Azure Azure Synapse Word Excel Outlook Veeva Vault CRM Coupa Agiloft

What Acadia Pharmaceuticals Is Building

◆Challenges

Ensuring trade compliance
Reimbursement challenges
Educational gaps
Maintaining inspection readiness
Improving access to innovative treatments
Implementing medication transitions of care
Therapy management strategies
Resource allocation
Cro quality compliance
Continuous improvement of quality management system

▲Active Projects

Preclinical safety assessment/toxicology programs
Global regulatory cmc strategy development
Medication transitions of care process implementation
Idn spp qbrs
Inspection readiness tools development
Implementation of quality system computerized systems
Portfolio governance improvement
Nonclinical tox/adme due diligence projects
Glp/gcp audit program
Implement ehr interventions

Hiring Activity

Steady130 roles · 40 in 30d

Department

Sales

Ops

Healthcare

Research

Support

Manufacturing

Marketing

Regulatory

Seniority

Senior

Director

Manager

Lead

Mid

Intern

Junior

Notable leadership hires: Director of Access, Medical Director, Head of Mid-Sized Countries, Alliance Management Director, Chemical Development Director

Company intelligence

Find more companies like Acadia Pharmaceuticals by tech stack, pain points and active projects

Get started free

About Acadia Pharmaceuticals

Acadia manufactures FDA-approved treatments for neurodegenerative and rare neuropsychiatric disorders, with current commercial products in Parkinson's psychosis and Rett syndrome. The company is developing mid-to-late-stage candidates in Alzheimer's psychosis and Lewy body dementia psychosis, alongside early-stage programs for other unmet neurological needs. Operations span clinical development, manufacturing, regulatory affairs, and commercial access; the company maintains a presence in the United States, Switzerland, and Germany. Scale sits at 501–1,000 employees with active recruitment emphasis on senior clinical, sales, and operational leadership.

HeadquartersSan Diego, California

Company Size501–1,000 employees

Hiring MarketsUnited States, Switzerland, Germany

Frequently Asked Questions

What tech stack does Acadia Pharmaceuticals use?

Veeva (CRM, Vault), Salesforce (core + Marketing Cloud), Microsoft Azure (with Synapse for analytics), NetSuite (finance), Coupa (procurement), Power BI, OneTrust (compliance), Agiloft (contract management), plus standard Office 365 and collaboration tools (Zoom, Webex).

What countries does Acadia Pharmaceuticals hire in?

United States, Switzerland, and Germany. Notable leadership roles include regional directors (Head of Mid-Sized Countries) and clinical/regulatory positions with geographic scope.